| Sandoz Pharmaceuticals AG - Omnitrope 5 mg, Injektionslösung |
| 61306 | | 01 | | Omnitrope 5 mg | | Injektionslösung | | H01AC01 | | Somatropin | | 27.07.2010 | | |
|
| Composition |
| somatropinum ADNr 5.0 mg corresp. 15.0 U.I., dinatrii phosphas heptahydricus, natrii dihydrogenophosphas dihydricus, poloxamerum 188, alcohol benzylicus 13.50 mg, mannitolum, natrii hydroxidum, acidum phosphoricum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 0.47 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Somatropinum Adnr | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Somatropinum Adnr | 5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Phosphorique | | | Alcohol Benzylicus | 13.5 mg | | Disodium Phosphate Heptahydrate | | | Mannitol | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
|
|
